Perioperative Tamsulosin for Prevention of Urinary Retention After Midurethral Sling Placement

Friday, October 6, 2023

12:30 PM – 12:34 PM US PST

Location: Oregon Ballroom

Click to View Image
Image Label: Patient characteristics

Click to View Image
Image Label: Propensity-matched multivariate analysis of factors associated with POUR

Presenting Author(s)

Susan Wherley, MD, MPS (she/her/hers)

Fellow
University Hospitals Cleveland Medical Center/MetroHealth Medical Center
Cleveland Heights, Ohio, United States

PDF

Co-Author(s)

Hope Bauer, MD (she/her/hers)

Female Pelvic Medicine and Reconstructive Surgery Fellow
Case Western Reserve University/University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
CM

Cathryn McBride, n/a

Medical Student
LMU-DCOM
Cleveland, Ohio, United States
David Sheyn, MD (he/him/his)

Associate Professor of Urology and Reproductive Biology Division Director, Female Pelvic Medicine and Reconstructive Surgery
University Hospitals System Urology Institute
Pepper pike, Ohio, United States

Disclosure(s):

Susan Wherley, MD, MPS: No financial relationships to disclose

Hope Bauer, MD: No financial relationships to disclose

Cathryn McBride, n/a: No financial relationships to disclose

David Sheyn, MD: Axonics: Clinical Trial Investigator (Ongoing); Caldera Medical: Advisor (Ongoing), Advisor (Ongoing), Advisor (Ongoing); CollaMedix: Consultant/Advisory Board (Ongoing), Stock-privately held company (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing); Renalis: Clinical Trial Investigator (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Investigator (Ongoing)

Should tamsulosin be routinely prescribed prior to retropubic midurethral sling placement? This study investigates the use of tamsulosin to reduce rates of urinary retention after sling placement, with or without concomitant prolapse repair. Attendees will leave with data to inform future practice.